Skip to main content
Log in

The intravenous insulin tolerance test is an accurate method for screening a general population for insulin resistance and related abnormalities

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

To verify whether the short intravenous insulin tolerance test (ITT) (a safe, reproducible, inexpensive, rapid and easy to perform measurement of insulin sensitivity) is a suitable test for insulin resistance screening in a general population, we measured in 60 non diabetic subjects, either non-obese (no.=40) or obese (BMI>28, no.=20) the K of glucose disappearance from plasma after ITT (KITT), plasma glucose (PG) and insulin (IRI) both fasting (FPG, FIRI) and at 120 min of OGTT (PG- 120, IRI- 120), and also triglycerides (Tg), cholesterol (Chol) and blood pressure (BP). Subjects were subdivided into quartiles according to KITT values. Average FPG, PG-120, FIRI, IRI-120, Tg and Chol values were progressively increased, and average HDL/Chol was progressively decreased from quartile 1 (the most insulin sensitive) to 4 (the most insulin resistant) (p<0.05, by 1-way ANOVA test). Also BP was increased in the insulin resistant patients, but statistical significance was not reached. Three or more of the studied parameters (FPG and/or PG-120, FIRI and/or IRI-120, Tg, HDL/Chol, mean BP) were altered (below the worst 25° percentile) in 64% of subjects from quartile 4; none of the subjects in quartile 1 was affected by such a cluster of alterations. KITT values ≤4.8 identified the cluster of insulin resistance related alterations with an accuracy of 82% (sensitivity=83.3%, specificity=80.5%). In healthy subjects with a wide range of BMI the ITT is a reliable procedure for screening for the cluster of metabolic alterations related to insulin resistance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Reaven G.M. Role of insulin resistance in human disease. Banting Lecture 1988. Diabetes 1988, 37: 1595–1607.

    Article  CAS  PubMed  Google Scholar 

  2. De Fronzo R.A., Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991, 14: 173–194.

    Article  Google Scholar 

  3. Reaven G.M. A syndrome of resistance to insulin-stimulated glucose uptake (Syndrome X): definition and implications. Cardiovasc. Risk Fact. 1993, 3: 2–11.

    Google Scholar 

  4. Hollenbeck G., Reaven G.M. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J. Clin. Endocrinol. Metab. 1987, 64: 1169–1173.

    Article  CAS  PubMed  Google Scholar 

  5. Pyorälä K., Savolainen E., Kaukola S., Haapakoski J. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9-year follow-up of the Helsinki policemen Study population. Acta Med. Scand. 1985 (Suppl.) 71: 38–52.

    Google Scholar 

  6. Fontbonne A.M., Eschiwege E.M. Insulin and cardiovascular disease: Paris Prospective Study. Diabetes Care 1991, 14: 461–469.

    Article  CAS  PubMed  Google Scholar 

  7. Zavaroni I., Bonora E., Pagliara M., Dall’Aglio E., Luchetti L., Buonanno G., Bonati P.A., Bergonzani M., Gundi L., Passeri M., Reaven G. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N. Engl. J. Med. 1989, 320: 702–706.

    Article  CAS  PubMed  Google Scholar 

  8. Haffner S.M., Valdez R.A., Hazuda H.P., Mitchell B.D., Morales P.A., Stern M.P. Prospective analysis of the insulin resistance syndrome (Syndrome X). Diabetes 1992, 41: 715–722.

    Article  CAS  PubMed  Google Scholar 

  9. De Fronzo R.A., Tobin J.D., Andres R. The glucose clamp technique: a method of quantifying insulin secretion and resistance. Am. J. Physiol. 1979, 237: E214–E223.

    Google Scholar 

  10. Bonora E., Moghetti P., Zancanaro C., Cigolini M., Querena M., Cacciatori V., Corgnati A., Muggeo M. Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycaemic clamp and hyperinsulinaemic clamp studies. J. Clin. Endocrinol. Metab. 1989, 68: 374–378.

    Article  CAS  PubMed  Google Scholar 

  11. Hirst S., Phillips D.I.W., Vines S.K., Clark P.M., Hales C.N. Reproducibility of the short insulin tolerance test. Diabet. Med. 1993, 10: 839.

    Article  CAS  PubMed  Google Scholar 

  12. Young R.P., Critchley J.A.J.H., Anderson P.J., Lau M.S.W., Lee K.K.C., Chan J.C.N. The short insulin tolerance test: feasibility study using venous sampling. Diabet. Med. 1996, 13: 429–433.

    Article  CAS  PubMed  Google Scholar 

  13. Akinmokun A., Selby P.L., Ramaiya K., Alberti K.G.M.M. The short insulin tolerance test for determination of insulin sensitivity: a comparison with the euglycaemic clamp. Diabet. Med. 1992, 9: 432–437.

    Article  CAS  PubMed  Google Scholar 

  14. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985, 28: 412–419.

    Article  CAS  PubMed  Google Scholar 

  15. Bonora E., Kiechl S., Willeit J., Oberhollenzer F., Egger G., Targher G., Alberiche M., Bonadonna R.C., Muggeo M. Prevalence of insulin resistance in metabolic disorders. The Bruneck Study. Diabetes 1998, 47: 1643–1649.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. Trischitta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Graci, S., Baratta, R., Degano, C. et al. The intravenous insulin tolerance test is an accurate method for screening a general population for insulin resistance and related abnormalities. J Endocrinol Invest 22, 472–475 (1999). https://doi.org/10.1007/BF03343592

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343592

Key-words

Navigation